In breast cancer cells, inhibition of CDK4/6 enhanced tumor antigen presentation, suppressed the proliferation of regulatory T-cells (T-reg), and promoted CD8 T-cell mediated tumor regression [107]. Here, CDK4 is linked to neoplasm.